Mood stabilizers in hospitalized children with bipolar disorder: A retrospective review
Authors:
- Pablo DavanzoPDPablo Davanzo
- Brent GundersonBGBrent Gunderson
- Thomas BelinTBThomas Belin
- Jim MintzJMJim Mintz
- Caroly PatakiCPCaroly Pataki
- Derek OttDODerek Ott
- Catherine Emley‐AkannoCECatherine Emley‐Akanno
- Jami OppenheimerJOJami Oppenheimer
- Michael StroberMSMichael Strober
Open Access
- 28 August 2003
- journal article
- research article
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 57 (5) , 504-510
Abstract
A paucity of naturalistic data supported a rationale for the present retrospective review of clinical changes during hospitalization in 44 bipolar pre‐adolescents, treated with monotherapy lithium, carbamazepine (CBZ) or divalproex sodium (DVP). Daily staff progress notes and discharge summaries on each patient were read by four trained clinicians blind to treatment group, and rated according to the Clinical Global Impression Improvement (CGI‐I) scale. Consensus rating was measured by kappa reliability. Data were analyzed using a general linear model (sas mixed) analysis of variance (anova) with repeated measures. The medication groups did not differ in length of hospitalization, overall severity of illness at the time of admission, or comorbidity. Prior treatment was considered as a covariate. Each group approached serum therapeutic levels at day 7 of the medication period. The estimated mean CGI‐I scores for CBZ were systematically higher (i.e. worse) than those for lithium and DVP, which overlapped and crossed over time. The difference became increasingly apparent and was statistically significant by week 2 (P = 0.036). The present study was limited in that the sample sizes, particularly in the case of CBZ, were small, commensurate with the low prevalence of the disorder. Lack of structured interviews, as an independent assessment of diagnoses was an intrinsic limitation of the study. Although constrained by its retrospective nature, our findings suggest that by week 2 of hospitalization both lithium and DVP may be more efficacious than CBZ in bipolar pre‐adolescents. Any significant finding must be viewed as tentative and subject to confirmation in other studies.Keywords
This publication has 25 references indexed in Scilit:
- Pattern of Response to Divalproex, Lithium, or Placebo in Four Naturalistic Subtypes of ManiaNeuropsychopharmacology, 2002
- DSM-IV Mania Symptoms in a Prepubertal and Early Adolescent Bipolar Disorder Phenotype Compared to Attention-Deficit Hyperactive and Normal ControlsJournal of Child and Adolescent Psychopharmacology, 2002
- The Stanley Foundation Bipolar NetworkThe British Journal of Psychiatry, 2001
- Efficacy of Olanzapine in Acute Bipolar ManiaA Double-blind, Placebo-Controlled StudyArchives of General Psychiatry, 2000
- The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorderInternational Clinical Psychopharmacology, 1999
- The Naturalistic Course of Pharmacologic Treatment of Children With Maniclike SymptomsThe Journal of Clinical Psychiatry, 1998
- Are childhood psychiatric histories of bipolar adolescents associated with family history, psychosis, and response to lithium treatment?Journal of Affective Disorders, 1998
- Carbamazepine Compared to Haloperidol in Acute ManiaInternational Clinical Psychopharmacology, 1989
- A family study of bipolar I disorder in adolescenceJournal of Affective Disorders, 1988
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978